AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Australian Cancer Technology Ltd, Australia, will be conducting the human trial of its p53 cancer vaccine in Aug 2001.
The vaccine is based on synthetic human antibodies from lymph nodes of colon cancer patients with mutated or …